🇺🇸 FDA
Patent

US 11730802

Zika vaccines and immunogenic compositions, and methods of using the same

granted A61KA61K2039/5252A61K2039/54

Quick answer

US patent 11730802 (Zika vaccines and immunogenic compositions, and methods of using the same) held by Takeda Vaccines, Inc. expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Vaccines, Inc.
Grant date
Tue Aug 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
67
CPC classes
A61K, A61K2039/5252, A61K2039/54, A61K2039/545, A61K2039/55505